Cetirizine is not a true anticholinergic, but it’s not completely free of anticholinergic activity either. In lab studies, cetirizine showed no measurable effect on muscarinic receptors even at high concentrations (100 μM), while it blocked histamine receptors at a fraction of that dose (0.12 μM). That’s a massive gap in selectivity, making cetirizine one of the most histamine-selective antihistamines available. Still, clinical scoring systems assign it a mild anticholinergic burden, and some users do experience subtle anticholinergic-type side effects like dry mouth.
What “Anticholinergic” Actually Means
Anticholinergic drugs block a chemical messenger called acetylcholine, which controls muscle contractions in your gut and bladder, saliva and mucus production, pupil size, and certain brain functions like memory. Classic anticholinergic side effects include dry mouth, constipation, blurry vision, urinary retention, and mental fogginess. First-generation antihistamines like diphenhydramine (Benadryl) are strongly anticholinergic because they bind to both histamine receptors and acetylcholine receptors with similar strength.
Cetirizine was designed to avoid this. It’s a second-generation antihistamine, derived from hydroxyzine (a first-generation drug with significant anticholinergic effects), but engineered to be far more selective for histamine receptors. Research published in BMC Pharmacology ranked cetirizine as one of the most selective antihistamines, showing no interaction with muscarinic (acetylcholine) receptors at the highest concentrations tested. By comparison, diphenhydramine and hydroxyzine both showed measurable muscarinic blockade.
Why Cetirizine Still Gets an Anticholinergic Score
If cetirizine doesn’t bind to acetylcholine receptors in lab studies, you might wonder why it shows up on anticholinergic burden scales at all. The Anticholinergic Cognitive Burden (ACB) scale, widely used in clinical practice, assigns cetirizine a score of 2 out of 3. A score of 1 means possible anticholinergic effects based on lab data, 2 means clinically relevant anticholinergic effects have been documented, and 3 means the drug is a potent anticholinergic.
The likely reason for this score is cetirizine’s real-world side effect profile. In clinical trials submitted to the FDA, 5% of people taking cetirizine reported dry mouth compared to 2.3% on placebo. Urinary retention was also reported, though in fewer than 2% of users, and a direct causal link wasn’t firmly established. These are classic anticholinergic symptoms, even if cetirizine’s mechanism for producing them may not involve direct muscarinic receptor blockade. The ACB scoring system weighs clinical observations alongside lab data, which explains the gap between what happens in a test tube and what shows up on the scale.
How Cetirizine Compares to First-Generation Antihistamines
The difference between cetirizine and older antihistamines is significant. Diphenhydramine is a strong anticholinergic that readily crosses into the brain, causing sedation in roughly 29% of users in one comparative trial. Cetirizine caused sedation in about 17% of the same study population. Beyond drowsiness, diphenhydramine produces the full range of anticholinergic effects: pronounced dry mouth, constipation, blurred vision, and confusion, particularly in older adults.
Cetirizine also has limited ability to reach the brain. Research on blood-brain barrier penetration found that cetirizine crossed into the central nervous system at roughly half the rate of terfenadine (another second-generation antihistamine) and far less than hydroxyzine or older drugs. This limited brain penetration is the main reason cetirizine causes less sedation and fewer cognitive side effects than first-generation options.
The 2023 American Geriatrics Society Beers Criteria, which flags medications that are risky for older adults, lists diphenhydramine and chlorpheniramine as drugs to avoid. Cetirizine, along with fexofenadine and loratadine, is recommended as a safer alternative for allergy treatment in this population.
Additive Effects With Other Medications
Even though cetirizine’s own anticholinergic activity is minimal, it can amplify side effects when taken alongside drugs that do have anticholinergic properties. Combining cetirizine with medications like muscle relaxants, tricyclic antidepressants, or bladder control drugs may increase dizziness, drowsiness, and difficulty concentrating. Older adults are especially sensitive to these additive effects.
This is where the ACB score matters practically. If you’re already taking one or two medications with anticholinergic properties, adding cetirizine contributes to your total anticholinergic “load.” Pharmacists and geriatricians often add up these scores across all of a patient’s medications. A combined score of 3 or higher is associated with increased risk of confusion, falls, and cognitive problems, particularly in people over 65.
Long-Term Use and Cognitive Concerns
A large cohort study following patients over 15 years found that antihistamine use in general was not significantly associated with dementia in the overall population. However, among people aged 65 and older, antihistamine users had a meaningfully higher risk of developing dementia compared to non-users. The study did not isolate cetirizine specifically, and the authors noted that second-generation antihistamines like cetirizine are less likely to affect the brain because they’re actively pumped back out of the central nervous system by a protein in the blood-brain barrier.
This means the cognitive risk from cetirizine is almost certainly lower than from first-generation drugs, but it hasn’t been proven to be zero, especially with long-term use in older adults. If you’re over 65 and taking cetirizine daily for months or years, this is worth discussing with a pharmacist, particularly if you’re also on other medications with anticholinergic effects.
Cetirizine vs. Other Second-Generation Options
Among second-generation antihistamines, cetirizine, fexofenadine, and loratadine all showed no muscarinic receptor activity in lab testing. Fexofenadine (Allegra) is generally considered the least sedating of the three and has the lowest reported rate of anticholinergic-type side effects. Loratadine (Claritin) falls in a similar range. Cetirizine tends to be slightly more sedating than both, which is consistent with its somewhat greater ability to reach the brain, but it’s also considered the most potent at blocking histamine among the three.
If you’re specifically concerned about anticholinergic effects, whether because of your age, your other medications, or a condition like glaucoma or an enlarged prostate, fexofenadine is the option least likely to cause problems. Cetirizine remains a reasonable choice for most people, but it’s not the cleanest option in the second-generation category when anticholinergic burden is the priority.